ScoreWhy is Shanghai Yizhong Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 281.52% and Operating profit at -25.62% over the last 5 years
2
The company has declared Negative results for the last 5 consecutive quarters
- NET SALES(9M) At CNY 163.41 MM has Grown at -19.12%
- NET PROFIT(9M) At CNY 3.38 MM has Grown at -94.81%
- OPERATING CASH FLOW(Y) Lowest at CNY -37.03 MM
3
With ROE of 0.29%, it has a very expensive valuation with a 8.45 Price to Book Value
- Over the past year, while the stock has generated a return of 10.18%, its profits have fallen by -95.4%
- At the current price, the company has a high dividend yield of 0
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Shanghai Yizhong Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Shanghai Yizhong Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Shanghai Yizhong Pharmaceutical Co., Ltd.
8.72%
1.50
54.04%
China Shanghai Composite
15.44%
1.01
14.52%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
281.52%
EBIT Growth (5y)
-25.62%
EBIT to Interest (avg)
80.83
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
0.19
Tax Ratio
39.09%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
32.26%
ROE (avg)
7.02%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
2881
Industry P/E
Price to Book Value
8.45
EV to EBIT
-984.95
EV to EBITDA
11664.53
EV to Capital Employed
13.23
EV to Sales
55.32
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1.34%
ROE (Latest)
0.29%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend19What is working for the Company
NET SALES(Q)
Highest at CNY 88.86 MM
OPERATING PROFIT(Q)
Highest at CNY 22.36 MM
OPERATING PROFIT MARGIN(Q)
Highest at 25.17 %
PRE-TAX PROFIT(Q)
Highest at CNY 24.65 MM
NET PROFIT(Q)
Highest at CNY 23.79 MM
EPS(Q)
Highest at CNY 0.12
-18What is not working for the Company
NET SALES(9M)
At CNY 163.41 MM has Grown at -19.12%
NET PROFIT(9M)
At CNY 3.38 MM has Grown at -94.81%
OPERATING CASH FLOW(Y)
Lowest at CNY -37.03 MM
DEBT-EQUITY RATIO
(HY)
Highest at -39.07 %
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.63%
RAW MATERIAL COST(Y)
Grown by 12.08% (YoY
Here's what is working for Shanghai Yizhong Pharmaceutical Co., Ltd.
Net Sales
At CNY 88.86 MM has Grown at 103.16%
over average net sales of the previous four periods of CNY 43.74 MMMOJO Watch
Near term sales trend is extremely positive
Net Sales (CNY MM)
Pre-Tax Profit
At CNY 24.65 MM has Grown at 599.54%
over average net sales of the previous four periods of CNY -4.93 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 23.79 MM has Grown at 752.65%
over average net sales of the previous four periods of CNY -3.65 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Net Sales
Highest at CNY 88.86 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Operating Profit
Highest at CNY 22.36 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Operating Profit Margin
Highest at 25.17 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at CNY 24.65 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 23.79 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.12
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Here's what is not working for Shanghai Yizhong Pharmaceutical Co., Ltd.
Operating Cash Flow
Lowest at CNY -37.03 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Debt-Equity Ratio
Highest at -39.07 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio
Lowest at 1.63% and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 12.08% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
